GlaxoSmithKline Finance Head Banned From Leaving China

by
editors
Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.
GlaxoSmithKline finance head banned from leaving China
 
 
Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.
 
The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.
 
 
Read it on BBC